Finch Therapeutics Group, Inc. FNCHQ
10.35
0.00
0.00%
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow FNCHQ
Growth Flags
show if company had growth for consecutive years
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 22.47 | 22.47 | 21.07 | 25.15 | 9.99 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (16.87) | (16.87) | (28.32) | (1.52) | (1.65) |
P/B ratio |
— | 0.00 | 0.00 | 1.93 | 0.23 | 0.27 |
Price to Tangible BV |
— | 0.00 | 0.00 | 2.12 | 0.34 | 0.00 |
EV/Sales |
— | 9.79 | 9.79 | 14.13 | (40.34) | 15.97 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.32 | 0.00 |
EV/Operating CF |
— | (2.41) | (2.41) | (3.90) | 0.46 | (0.31) |
EV/FCF |
— | (2.22) | (2.22) | (3.15) | 0.45 | (0.32) |
Quick Ratio |
— | 6.41 | 8.78 | 9.06 | 4.85 | 6.15 |
Current Ratio |
— | 6.64 | 9.24 | 9.64 | 5.08 | 6.33 |
Net Debt/EBITDA |
— | (4.89) | 2.53 | 2.23 | 0.51 | 0.31 |
Debt/Assets |
0.00% | 132.23% | 1.09% | 2.17% | 8.99% | 0.00% |
Debt/Equity |
— | (2.40) | 0.01 | 0.02 | 0.15 | 0.00 |
Asset Turnover |
— | 0.19 | 0.06 | 0.09 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.83 | 0.80 | 1.15 | 0.65 | 0.42 |
Capex/Depreciation |
— | 0.00 | (3.33) | (6.92) | (0.40) | 0.87 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 26.74% | 50.68% | (109.21%) | (76.96%) | (126.06%) | |
| — | (38.34%) | (28.76%) | (29.77%) | (59.05%) | (68.48%) | |
ROIC |
— | 0.00% | (62.50%) | (50.92%) | (183.71%) | 0.00% |
Return on Tangible Assets |
— | (46.04%) | (38.69%) | (39.46%) | (151.25%) | (334.37%) |
Average Days of Receivables |
— | 170.60 | 51.78 | 9.73 | 61.05 | 0.00 |
Research and Development Expense of Revenue |
— | 227.11% | 429.38% | 309.08% | 6,139.72% | 6,728.04% |
Selling, General and Administrative Expense of Revenue |
— | 73.26% | 181.51% | 114.60% | 4,203.48% | 25,149.53% |
Intangible Assets out of Total Assets |
0.00 | 0.47 | 0.11 | 0.08 | 0.20 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 40.15% | 22.45% | 911.03% | 1,802.80% |
Graham Net Nets |
— | 0.45 | 0.45 | 0.31 | 0.34 | (1.08) |
Graham Number |
— | 0.00 | 1,073.24 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (22.68%) | (22.68%) | (19.38%) | (531.37%) | (1,247.91%) |
Free Cash Flow Yield |
— | (19.58%) | (19.58%) | (21.27%) | (355.72%) | (492.21%) |
Revenue per Share |
— | 6.31 | 28.46 | 14.20 | 0.54 | 0.07 |
Operating CF per Share |
— | (10.76) | (115.52) | (51.43) | (47.08) | (19.63) |
Capex per Share |
— | 0.00 | (9.71) | (12.20) | (1.37) | 0.83 |
Free Cash Flow per Share |
— | (10.76) | (125.23) | (63.62) | (48.45) | (18.80) |
Cash per Share |
— | 26.22 | 367.66 | 102.25 | 44.68 | 15.65 |
Shareholders Equity per Share |
— | (37.00) | 506.40 | 154.91 | 60.20 | 14.26 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (37.00) | 506.40 | 154.91 | 60.20 | 14.26 |
Free Cash Flow |
— | (17.32) | (33.96) | (83.05) | (77.03) | (30.18) |
Working Capital |
— | 41.30 | 94.68 | 127.76 | 59.86 | 21.76 |
Capital Expenditures |
— | (1.00) | (2.63) | (15.92) | (2.18) | 1.33 |
Net Current Asset Value |
— | (119.17) | 78.16 | 119.41 | 7.32 | (6.64) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.30 | 0.00 |
Capex to Sales |
— | 0.00 | 0.34 | 0.86 | 2.53 | (12.40) |
Net Profit Margin |
— | (204.39%) | (509.66%) | (313.84%) | (13,315.45%) | (69,863.55%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
— | 0.13 | 0.11 | 0.12 | 0.35 | 2.56 |
Cash ROIC |
— | (16.77%) | (16.05%) | (25.48%) | (50.05%) | (66.86%) |
Accounts Receivable Turnover |
— | 3.48 | 2.64 | 23.33 | 2.70 | 0.00 |
Accounts Payable Turnover |
— | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | — | — | 0.00 | — |
Average Days of Payables |
— | 300.35 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 19.72 | — | — | 0.00 | — |
Average Receivables |
— | 2.92 | 2.92 | 0.79 | 0.32 | — |
Average Payables |
— | 1.64 | 1.64 | 3.18 | 2.42 | 0.62 |
Average Assets |
— | 54.13 | 136.80 | 195.35 | 194.15 | 109.16 |
Average Common Equity |
— | (77.63) | (77.63) | 53.25 | 148.97 | 59.30 |
Columns are period end dates